Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
gptkb:Luminex_Corporation
|
| gptkbp:awards |
gptkb:Frost_&_Sullivan_Award
Best New Technology |
| gptkbp:CEO |
gptkb:R._Scott_McCulloch
|
| gptkbp:collaborations |
gptkb:FDA
gptkb:NCI NIH academic institutions research institutions biopharmaceutical companies |
| gptkbp:conference |
gptkb:ESMO_Congress
ASCO Annual Meeting AACR Annual Meeting SABCS |
| gptkbp:employees |
approximately 300
|
| gptkbp:focus |
molecular diagnostics
gene expression analysis spatial biology |
| gptkbp:founded |
2003
|
| gptkbp:founder |
gptkb:Bradley_R._Gray
|
| gptkbp:headquarters |
gptkb:Seattle,_Washington
|
| https://www.w3.org/2000/01/rdf-schema#label |
NanoString Technologies
|
| gptkbp:industry |
genomics
|
| gptkbp:market |
personalized medicine
clinical research pharmaceutical development biomarker_discovery |
| gptkbp:partnerships |
gptkb:AstraZeneca
gptkb:Merck_&_Co. |
| gptkbp:patentCitation |
spatial transcriptomics
molecular imaging gene expression technology |
| gptkbp:products |
gptkb:GeoMx_Digital_Spatial_Profiler
nCounter Analysis System |
| gptkbp:research_focus |
rare diseases
autoimmune diseases neuroscience regenerative medicine cardiovascular diseases infectious diseases developmental biology cancer genomics metabolic diseases immune profiling |
| gptkbp:stockExchange |
gptkb:NASDAQ
NSTG |
| gptkbp:technology |
DNA profiling
RNA profiling barcoded probes digital spatial profiling |
| gptkbp:website |
www.nanostring.com
|